The store will not work correctly when cookies are disabled.
3-benzylamino-6-chloro-4H-thieno[3,2-e]-1,2,4-thiadiazine1,1-dioxide
ID: ALA378871
PubChem CID: 135432934
Max Phase: Preclinical
Molecular Formula: C12H10ClN3O2S2
Molecular Weight: 327.82
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S1(=O)NC(NCc2ccccc2)=Nc2cc(Cl)sc21
Standard InChI: InChI=1S/C12H10ClN3O2S2/c13-10-6-9-11(19-10)20(17,18)16-12(15-9)14-7-8-4-2-1-3-5-8/h1-6H,7H2,(H2,14,15,16)
Standard InChI Key: YWTJUVYOMJNPAE-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.0152 -12.7600 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.3027 -12.3538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3027 -11.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0152 -11.1101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5123 -12.6061 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.7278 -12.3538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7277 -11.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5132 -11.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9935 -11.9421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4344 -13.3446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6034 -13.3446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5865 -11.1163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8184 -11.9443 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.1274 -11.5330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8435 -11.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5541 -11.5407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2656 -11.1289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2685 -10.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5538 -9.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8410 -10.3008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
1 10 2 0
6 7 2 0
1 11 2 0
3 12 1 0
7 4 1 0
9 13 1 0
6 1 1 0
12 14 1 0
1 2 1 0
14 15 1 0
2 3 1 0
15 16 2 0
5 6 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
20 15 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.82 | Molecular Weight (Monoisotopic): 326.9903 | AlogP: 2.47 | #Rotatable Bonds: 2 |
Polar Surface Area: 70.56 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.48 | CX Basic pKa: 1.17 | CX LogP: 2.97 | CX LogD: 2.07 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.89 | Np Likeness Score: -1.18 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |